To attenuate the inhibitory effect of GPX4 on ferroptosis in the treatment of colorectal cancer, Chen et al. developed a hypoxia-responsive nanoelicitor (HRNE) that effectively exerts ferroptosis by inducing tumor-killing solid immunity. This evidence concerns the gene GPX4 and neoplasm.